Mechanism
Raises blood glucose by mobilizing hepatic glycogen — the emergency antidote for severe hypoglycemia.
TechnicalGlucagon receptor (GPCR) → ↑cAMP → glycogenolysis and gluconeogenesis.
Reported uses by species
| Species | Indication | Tier | Honest evidence note |
|---|---|---|---|
| Dogs & Cats | Severe hypoglycemia rescue | Standard-of-care | Insulinoma, insulin overdose, neonatal hypoglycemia. |
| Cattle | Fatty-liver disease | Standard-of-care | Adjunctive metabolic management. |
Suggested starting protocol
Starting points only — clinical judgment required. Dosing unlocks for verified veterinary accounts.
Professional-use acknowledgment
Confirm you are a veterinary professional
Dosing tables on monographs are for licensed veterinary professionals using independent clinical judgment.
- • I am a licensed veterinary professional accessing this content for clinical use.
- • I will exercise independent clinical judgment for every patient.
- • I understand evidence labels reflect the current state of published research.
Monitoring, contraindications & do-not-use-if
Pheochromocytoma, insulinoma (causes rebound insulin release — use under hospital monitoring).
The evidence
- Peptides in Veterinary Medicine — BachemBachem